Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes

Necroptosis, a kind of programmed necrotic cell apoptosis, is the gatekeeper for the host to defend against the invasion of pathogens. It helps to regulate different biological processes regarding human cancer. Nevertheless, studies that determine the impact of death on triple-negative breast cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Luo, Zhaoqi Shi, Changshou He, Guojun Chen, Ji Feng, Linghua Zhu, Xiangyang Song
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2023/8427767
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548001271250944
author Peng Luo
Zhaoqi Shi
Changshou He
Guojun Chen
Ji Feng
Linghua Zhu
Xiangyang Song
author_facet Peng Luo
Zhaoqi Shi
Changshou He
Guojun Chen
Ji Feng
Linghua Zhu
Xiangyang Song
author_sort Peng Luo
collection DOAJ
description Necroptosis, a kind of programmed necrotic cell apoptosis, is the gatekeeper for the host to defend against the invasion of pathogens. It helps to regulate different biological processes regarding human cancer. Nevertheless, studies that determine the impact of death on triple-negative breast cancer (TNBC) are scarce. Therefore, this paper has comprehensively examined the expression as well as clinical significance of necroptosis in TNBC. ConsensusClusterPlus was used to establish a stable molecular classification that used the expression regarding the necroptosis-linked genes. The clinical and immune characteristics of different subclasses were evaluated. Then, the weighted gene coexpression network analysis (WGCNA) assisted in determining key modules, and we selected the genes exhibiting obvious association with necroptosis prognosis through the relationship with prognosis. The univariate Cox regression analysis together with least absolute shrinkage and selection operator (LASSO) techniques served for the construction of the necroptosis-related prognostic risk score (NPRS) model, and the pathway characteristics of NPRS model grouping were further studied. Finally, the NPRS, taking into account the clinicopathological features, used the decision tree model for enhancing the prognostic model as well as the survival prediction. First, two stable molecular subtypes with different prognosis and immune characteristics were identified using necroptosis marker genes. Then, the key modules were identified, and 10 genes significantly related to the prognosis of necroptosis were selected. Then, the clinical prognostic model of NPRS was developed considering the prognosis-linked necroptosis genes. Finally, the NPRS model, taking into account the clinicopathological features, adopted the decision tree model for enhancing the prognostic model as well as the survival prediction. Herein, two new molecular subgroups considering necroptosis-linked genes are proposed, and an NPRS model composed of 10 genes is developed, which maybe assist in the personalized treatment and clinical treatment guidance of TNBC patients.
format Article
id doaj-art-9586d47f87a64e72bc4e2cce25dbd81a
institution Kabale University
issn 1687-9678
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-9586d47f87a64e72bc4e2cce25dbd81a2025-02-03T06:42:38ZengWileyStem Cells International1687-96782023-01-01202310.1155/2023/8427767Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular SubtypesPeng Luo0Zhaoqi Shi1Changshou He2Guojun Chen3Ji Feng4Linghua Zhu5Xiangyang Song6Department of General SurgeryDepartment of General SurgeryDepartment of OncologyDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of Surgical OncologyNecroptosis, a kind of programmed necrotic cell apoptosis, is the gatekeeper for the host to defend against the invasion of pathogens. It helps to regulate different biological processes regarding human cancer. Nevertheless, studies that determine the impact of death on triple-negative breast cancer (TNBC) are scarce. Therefore, this paper has comprehensively examined the expression as well as clinical significance of necroptosis in TNBC. ConsensusClusterPlus was used to establish a stable molecular classification that used the expression regarding the necroptosis-linked genes. The clinical and immune characteristics of different subclasses were evaluated. Then, the weighted gene coexpression network analysis (WGCNA) assisted in determining key modules, and we selected the genes exhibiting obvious association with necroptosis prognosis through the relationship with prognosis. The univariate Cox regression analysis together with least absolute shrinkage and selection operator (LASSO) techniques served for the construction of the necroptosis-related prognostic risk score (NPRS) model, and the pathway characteristics of NPRS model grouping were further studied. Finally, the NPRS, taking into account the clinicopathological features, used the decision tree model for enhancing the prognostic model as well as the survival prediction. First, two stable molecular subtypes with different prognosis and immune characteristics were identified using necroptosis marker genes. Then, the key modules were identified, and 10 genes significantly related to the prognosis of necroptosis were selected. Then, the clinical prognostic model of NPRS was developed considering the prognosis-linked necroptosis genes. Finally, the NPRS model, taking into account the clinicopathological features, adopted the decision tree model for enhancing the prognostic model as well as the survival prediction. Herein, two new molecular subgroups considering necroptosis-linked genes are proposed, and an NPRS model composed of 10 genes is developed, which maybe assist in the personalized treatment and clinical treatment guidance of TNBC patients.http://dx.doi.org/10.1155/2023/8427767
spellingShingle Peng Luo
Zhaoqi Shi
Changshou He
Guojun Chen
Ji Feng
Linghua Zhu
Xiangyang Song
Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
Stem Cells International
title Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
title_full Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
title_fullStr Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
title_full_unstemmed Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
title_short Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
title_sort predicting the clinical outcome of triple negative breast cancer based on the gene expression characteristics of necroptosis and different molecular subtypes
url http://dx.doi.org/10.1155/2023/8427767
work_keys_str_mv AT pengluo predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT zhaoqishi predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT changshouhe predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT guojunchen predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT jifeng predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT linghuazhu predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes
AT xiangyangsong predictingtheclinicaloutcomeoftriplenegativebreastcancerbasedonthegeneexpressioncharacteristicsofnecroptosisanddifferentmolecularsubtypes